FIRM NEWS

January 4, 2018

Lucosky Brookman congratulates its client, Akers Biosciences, Inc. (OTC: AKER), a developer of rapid health information technologies.  On December 21, 2017 the Company closed on a public offering of $6 million issuing an aggregate of (i) 15,500,000 Class A Units consis...

Please reload

Please reload

ARCHIVE
Please reload

RECENT POSTS
FEATURED POSTS

Firm Represents Client Directview Holdings, Inc. in Negotiation and Restructuring of $9,000,000 of Debt, Potentially Cancelling $6,000,000 of Debt

October 15, 2019

1/6
Please reload